shadow_tr

Back to the search results page

John Scott

John Scott, MD,PhD

Assistant Professor of Pathology

Department: Pathology

Phone: 504-988-5224

Home Page: Click here for Physician's Web Page

Sections: Pathology

Languages: English

Interests: Clinical Pathology, Medical Education, Molecular Pathology

Make an appointment



Professional Profile

Medical Education

  • BS, Pacific Union College, Angwin, CA, 1968
  • Fellowship, The Methodist Hospital Department of Pathology, Houston, TX, 2008
  • Fellowship, Tulane University School of Medicine, New Orleans, LA, 2008
  • Fellowship, Oregon Health Sciences University, Portland, OR, 1991
  • Internship/Residency, St. Joseph's Hospital, Paterson, NJ, 1988
  • MA, Pacific Union College, Angwin, CA, 1968
  • MD, University of L'Aquila, School of Medicine, L'Aquila, Italy, 1985
  • PhD, University of Oregon School of Medicine  , Portland, OR  , 1974
  • Postdoctoral Fellow, University of Washington, Seattle, WA, 1976
  • Residency, Tulane University School of Medicine, New Orleans, LA, 2006
  • Residency, The Methodist Hospital, Houston, TX, 2006
  • Residency, Danbury Hospital, Danbury, CT, 1992

Board Certification

  • Board Certified in Clinical Pathology

Publications

  • Treatment of Refractory Lupus Nephritis with Stem Cell Transplantation. , Southern Medical Journal, October 8, 1998, Miller, A., Batuman and SCOTT, J
  • Remicade (Infliximab) in patients with Systemic Lupus Erythematosus and Leukopenia. , American Academy of Rheumatology, Oct 2002, JOHN W. SCOTT, M.D., Tayler Huynh Le, Pharm.D, Jeanette H. Magnus, M.D.
  • Chronic Myelogenous Leukemia and Porphyria Cutanea Tarda in a Patient with Limited Systemic Sclerosis., Southern Medical Journal, May 1998, Wooten, MD, SCOTT, JW, Miller, AM and Boh, E.
  • Experience with Remicade (Infliximab) in the Treatment of Mixed Connective Tissue Disease/Lupus., EULAR, July 2002, JOHN W. SCOTT, M.D., Alona Franciois, Tayler Hynh-Le Pharm D.
  • Virtual Problem-Based Learning (VPBL): Design experimentation for curricular deployment., Instructional Science Special Edition, Issue 1, Bruce E. Bowdish, Sheila W. Chauvin, Norman Kreisman, JOHN W. SCOTT, Mike Britt
  • Probability of Anti-D Antibody Development Among Rh negative Hospitalized Patients Receiving Rh Positive Packed Red Blood Cells, AABB Meetings, 2007, R Davey and J SCOTT
  • Stem Cell Transplantation for the Treatment of Refractory Lupus Nephritis., Show Chwan Medical Journal, 2001, Alan Miller Ph.D. M.D., JOHN W. SCOTT Ph.D. M.D.
  • Effective Treatment of Systemic Lupus Erythematosus with high Dose Cyclophosphamide Followed by G-CSF., Southern Regional Meetings, 1999, JW SCOTT
  • Plasmid independent penicillin resistance and Beta-lactamase activity in Bacteroides fragilis., American Society for Microbiology Northwest Branch Meeting, 1976, SCOTT, JW, Elwell, L and Falkow, S
  • Clinical evaluation of the rapid hippurate analysis for the identification of Group B Streptococci, Quaderno Sclavo Diagnostico, Scott, Jw and McDowel, N
  • R17 Bacteriophage replicase association with the inhibition of QB, fd and Beta‐galactosidase production, Journal of Virology, Scott, Jw and Iglewski, WJ
  • Elimination of the early inhibition of protein synthesis in Escherichia coli C 3000 infected with purified R17 bacteriophage., Journal of Virology, Scott, Jw and Iglewski, WJ
  • Regression of scleroderma following an allogeneic bone marrow transplant for chronic myelogenous leukemia., Tulane University Medical Center, Departments of Medicine and Dermatology, Miller, AM, Wooten, MD, SCOTT, JW, Boh, E and Rink, J.

1415 Tulane Ave, New Orleans, LA 70112  504-988-5800 website@tulane.edu